MYCIO Wealth Partners’s AstraZeneca AZN Stock Holding History

MYCIO Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-400	Closed	-$26K	–	254
2016 Q3	$26K	Sell	400 -77	-16%	-$5.03K	﹤0.01%	436
2016 Q2	$29K	Buy	477 +77	+19%	+$4.47K	0.01%	409
2016 Q1	$23K	Hold	400	–	–	﹤0.01%	416
2015 Q4	$27K	Hold	400	–	–	﹤0.01%	372
2015 Q3	$25K	Hold	400	–	–	0.01%	401
2015 Q2	$25K	Buy	+400	New	+$27.4K	﹤0.01%	396

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

MYCIO Wealth Partners's AZN Position: Q4 2016 in Review

MYCIO Wealth Partners sold out of AstraZeneca (AZN) in Q4 2016, closing a stake of 400 shares — an estimated $26K sold.

MYCIO Wealth Partners first reported a position in AZN in Q2 2015 and held it in 6 quarters. The position peaked at $29K in Q2 2016. 450 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

MYCIO Wealth Partners reported no remaining AstraZeneca position as of Q4 2016 after selling out during the quarter.
MYCIO Wealth Partners sold 400 AstraZeneca shares in Q4 2016, an estimated $26K.
MYCIO Wealth Partners first reported a position in AstraZeneca in Q2 2015 and held it in 6 quarters.
MYCIO Wealth Partners's AstraZeneca position peaked at $29K in Q2 2016.
450 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on MYCIO Wealth Partners's 13F filing for Q4 2016, filed 1 Feb 2017.